{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:36Z","timestamp":1792834716856,"version":"4.5.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Guillain-Barr\u00e9 syndrome (GBS) is an immune-mediated polyneurogenic disorder that is strongly correlated with immune factors. However, causal relationships between these factors remain unclear. We used 2-sample Mendelian randomization (MR) and inverse MR analysis. Immune factors were used as the outcome for GBS exposure. Cochrane\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      test was used to detect heterogeneity. Simultaneously, the MR-Egger intercept test and MR-Pleiotropy Residual Sum and Outlier tests were used to check for horizontal pleiotropy. MR Steiger was used to estimate the direction of causal inference when the instrumental variables were insufficient in inverse MR. Eighteen immune traits and 1 inflammatory protein were identified as causally involved in the risk of GBS. Reverse MR revealed that GBS was correlated with the levels of eleven immune traits. The sensitivity analyses did not identify any potential heterogeneity or horizontal pleiotropy. Steiger did not find any evidence of reverse causation. We used 2-sample MR to investigate the causal relationship between immune factors and GBS, and our results provide clues for further research.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050444","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:00:09Z","timestamp":1787968809000},"page":"e50444","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between immune factors and Guillain-Barr\u00e9 syndrome"],"prefix":"10.1097","volume":"105","author":[{"given":"Taichuan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Spine, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfa","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1579-1516","authenticated-orcid":false,"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Spine, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"R2-20261024","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis.","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"R3-20261024","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","article-title":"Pain in Guillain-Barre syndrome: a long-term follow-up study.","volume":"75","author":"Ruts","year":"2010","journal-title":"Neurology"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","article-title":"Outcome and its predictors in Guillain-Barre syndrome.","volume":"83","author":"Rajabally","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis.","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"R7-20261024","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.51","article-title":"TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome.","volume":"68","author":"Nyati","year":"2011","journal-title":"Arch Neurol"},{"key":"R8-20261024","doi-asserted-by":"crossref","first-page":"740947","DOI":"10.1155\/2014\/740947","article-title":"Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barr\u00e9 syndrome and downregulated by IVIg treatments.","volume":"2014","author":"Li","year":"2014","journal-title":"Mediators Inflamm"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"613628","DOI":"10.3389\/fnagi.2020.613628","article-title":"The neuroimmunology of Guillain-Barr\u00e9 syndrome and the potential role of an aging immune system.","volume":"12","author":"Hagen","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis.","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine (Baltimore)"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"639712","DOI":"10.1155\/2013\/639712","article-title":"Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barr\u00e9 syndrome.","volume":"2013","author":"Li","year":"2013","journal-title":"Mediators Inflamm"},{"key":"R12-20261024","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2009.10.001","article-title":"Conversion of peripheral CD4(+)CD25(-) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain-Barr\u00e9 syndrome.","volume":"217","author":"Huang","year":"2009","journal-title":"J Neuroimmunol"},{"key":"R13-20261024","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2012.02.011","article-title":"IFN-\u03b3 deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response.","volume":"246","author":"Zhang","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"1325262","DOI":"10.1155\/sci\/1325262","article-title":"Discovery of PAK2 as a key regulator of cancer stem cell in head and neck squamous cell carcinoma using multi-omic techniques.","volume":"2025","author":"Wang","year":"2025","journal-title":"Stem Cells Int"},{"key":"R15-20261024","doi-asserted-by":"crossref","first-page":"1678907","DOI":"10.3389\/fimmu.2025.1678907","article-title":"Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies.","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"R16-20261024","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1186\/s12885-025-14246-1","article-title":"Interplay of disulfidptosis and the tumor microenvironment across cancers: implications for prognosis and therapeutic responses.","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Cancer"},{"key":"R17-20261024","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R18-20261024","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-024-02013-y","article-title":"N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.","volume":"23","author":"Wen","year":"2024","journal-title":"Mol Cancer"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/biomedicines11030825","article-title":"HIF-1\u03b1-overexpressing mesenchymal stem cells attenuate colitis by regulating M1-like macrophages polarization toward M2-like macrophages.","volume":"11","author":"Zhu","year":"2023","journal-title":"Biomedicines"},{"key":"R20-20261024","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/s41418-025-01533-4","article-title":"KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression.","volume":"32","author":"Zhang","year":"2025","journal-title":"Cell Death Differ"},{"key":"R21-20261024","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/02770903.2024.2403740","article-title":"Causal links between immune cells and asthma: insights from a Mendelian randomization analysis.","volume":"62","author":"Xu","year":"2025","journal-title":"J Asthma"},{"key":"R22-20261024","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R23-20261024","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orru","year":"2020","journal-title":"Nat Genet"},{"key":"R24-20261024","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R25-20261024","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R26-20261024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12916-023-02736-7","article-title":"Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study.","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Med"},{"key":"R27-20261024","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods.","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"key":"R28-20261024","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R29-20261024","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12672-025-02654-5","article-title":"Exploring the causal relationship between immune factors and chondrosarcoma: a Mendelian randomization study.","volume":"16","author":"Xu","year":"2025","journal-title":"Discov Oncol"},{"key":"R30-20261024","doi-asserted-by":"crossref","first-page":"e0305214","DOI":"10.1371\/journal.pone.0305214","article-title":"Is there a causal relationship between resistin levels and bone mineral density, fracture occurrence? A mendelian randomization study.","volume":"19","author":"Xu","year":"2024","journal-title":"PLoS One"},{"key":"R31-20261024","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12967-024-04996-0","article-title":"Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease.","volume":"22","author":"Yan","year":"2024","journal-title":"J Transl Med"},{"key":"R32-20261024","doi-asserted-by":"crossref","first-page":"103592","DOI":"10.1016\/j.ebiom.2021.103592","article-title":"Kidney damage causally affects the brain cortical structure: a mendelian randomization study.","volume":"72","author":"Chen","year":"2021","journal-title":"EBioMedicine"},{"key":"R33-20261024","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R34-20261024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14728222.2024.2330435","article-title":"Guillain-Barr\u00e9 syndrome: immunopathogenesis and therapeutic targets.","volume":"28","author":"Liu","year":"2024","journal-title":"Expert Opin Ther Targets"},{"key":"R35-20261024","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis.","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"R36-20261024","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2174\/1570159X14666161213114904","article-title":"Biological drugs in Guillain-Barr\u00e9 syndrome: an update.","volume":"15","author":"Motamed-Gorji","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"R37-20261024","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00415-012-6806-x","article-title":"Long-term outcome in patients with Guillain-Barr\u00e9 syndrome requiring mechanical ventilation.","volume":"260","author":"Witsch","year":"2013","journal-title":"J Neurol"},{"key":"R38-20261024","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps.","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"R39-20261024","doi-asserted-by":"crossref","first-page":"564098","DOI":"10.1155\/2015\/564098","article-title":"Biomarkers of Guillain-Barr\u00e9 syndrome: some recent progress, more still to be explored.","volume":"2015","author":"Wang","year":"2015","journal-title":"Mediators Inflamm"},{"key":"R40-20261024","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s13311-021-01117-3","article-title":"Novel immunological and therapeutic insights in Guillain-Barr\u00e9 syndrome and CIDP.","volume":"18","author":"Querol","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"Pt A","key":"R41-20261024","doi-asserted-by":"crossref","first-page":"107055","DOI":"10.1016\/j.intimp.2020.107055","article-title":"Implications of CD39 in immune-related diseases.","volume":"89","author":"Zeng","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R42-20261024","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1600-6143.2010.03291.x","article-title":"Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.","volume":"10","author":"Dwyer","year":"2010","journal-title":"Am J Transplant"},{"key":"R43-20261024","doi-asserted-by":"crossref","first-page":"e21386","DOI":"10.1371\/journal.pone.0021386","article-title":"T regulatory cells are markers of disease activity in multiple sclerosis patients.","volume":"6","author":"Dalla Libera","year":"2011","journal-title":"PLoS One"},{"key":"R44-20261024","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.","volume":"183","author":"Fletcher","year":"2009","journal-title":"J Immunol"},{"key":"R45-20261024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2011.09.013","article-title":"Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.","volume":"240-241","author":"Peelen","year":"2011","journal-title":"J Neuroimmunol"},{"key":"R46-20261024","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1177\/1352458514567215","article-title":"Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse.","volume":"21","author":"Muls","year":"2015","journal-title":"Mult Scler"},{"key":"R47-20261024","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1038\/s41598-019-38897-w","article-title":"Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients.","volume":"9","author":"Alvarez-Sanchez","year":"2019","journal-title":"Sci Rep"},{"key":"R48-20261024","doi-asserted-by":"crossref","first-page":"155054","DOI":"10.1016\/j.cyto.2020.155054","article-title":"Discriminative expression of CD39 and CD73 in cerebrospinal fluid of patients with multiple sclerosis and Neuro-Beh\u00e7et's disease.","volume":"130","author":"Bahrini","year":"2020","journal-title":"Cytokine"},{"key":"R49-20261024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2018.10.032","article-title":"Activity and expression of E-NTPDase is altered in peripheral lymphocytes of systemic lupus erythematosus patients.","volume":"488","author":"Becker","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R50-20261024","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10620-010-1425-9","article-title":"Variable impact of CD39 in experimental murine colitis.","volume":"56","author":"Kunzli","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R51-20261024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2014.12.007","article-title":"The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation.","volume":"58","author":"Rissiek","year":"2015","journal-title":"J Autoimmun"},{"key":"R52-20261024","doi-asserted-by":"crossref","first-page":"102945","DOI":"10.1016\/j.jaut.2022.102945","article-title":"Notch signaling dependent monocyte conversion alleviates immune-mediated neuropathies by regulating RBP-J\/NR4A1 axis.","volume":"133","author":"Ren","year":"2022","journal-title":"J Autoimmun"},{"key":"R53-20261024","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/ijlh.12845","article-title":"Can we assess severity of Guillain-Barr\u00e9 syndrome using absolute monocyte count?","volume":"40","author":"Li","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"R54-20261024","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/icb.2014.15","article-title":"Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.","volume":"92","author":"Chuluundorj","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"R55-20261024","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1742-2094-10-35","article-title":"Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.","volume":"10","author":"Vogel","year":"2013","journal-title":"J Neuroinflammation"},{"key":"R56-20261024","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jneuroim.2019.03.005","article-title":"Association of circulating anti-CD64 IgM levels with favourable long-term clinical outcomes in multiple sclerosis patients.","volume":"330","author":"Annunziata","year":"2019","journal-title":"J Neuroimmunol"},{"key":"R57-20261024","doi-asserted-by":"crossref","first-page":"116371","DOI":"10.1016\/j.biopha.2024.116371","article-title":"Therapeutic potential of natural killer cells in neuroimmunological diseases.","volume":"173","author":"Zhang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R58-20261024","doi-asserted-by":"crossref","first-page":"e00120","DOI":"10.1128\/mSphereDirect.00120-18","article-title":"Zika virus infection preferentially counterbalances human peripheral monocyte and\/or NK cell activity.","volume":"3","author":"Lum","year":"2018","journal-title":"mSphere"},{"key":"R59-20261024","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present yourself! By MHC Class I and MHC Class II molecules.","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol"},{"key":"R60-20261024","doi-asserted-by":"crossref","first-page":"301","DOI":"10.17712\/1658-3183.2099","article-title":"Association between human leukocyte antigen-DR and demylinating Guillain-Barre syndrome.","volume":"19","author":"Hasan","year":"2014","journal-title":"Neurosciences (Riyadh)"},{"key":"R61-20261024","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.170.6.3074","article-title":"Differential distribution of HLA-DQ beta\/DR beta epitopes in the two forms of Guillain-Barr\u00e9 syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP.","volume":"170","author":"Magira","year":"2003","journal-title":"J Immunol"},{"key":"R62-20261024","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0972-2327.104341","article-title":"A report of a probable case of familial Guillain Barre syndrome.","volume":"15","author":"Barzegar","year":"2012","journal-title":"Ann Indian Acad Neurol"},{"key":"R63-20261024","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.3390\/ijms25094609","article-title":"HLA-DR expression in natural killer cells marks distinct functional states, depending on cell differentiation stage.","volume":"25","author":"Kust","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R64-20261024","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.4049\/jimmunol.177.8.5659","article-title":"Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis.","volume":"177","author":"Aranami","year":"2006","journal-title":"J Immunol"},{"key":"R65-20261024","doi-asserted-by":"crossref","first-page":"25400","DOI":"10.1074\/jbc.M110793200","article-title":"Delta\/notch-like epidermal growth factor (EGF)-related receptor, a novel EGF-like repeat-containing protein targeted to dendrites of developing and adult central nervous system neurons.","volume":"277","author":"Eiraku","year":"2002","journal-title":"J Biol Chem"},{"key":"R66-20261024","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajmg.1245","article-title":"Holoprosencephaly associated with an apparent isolated 2q37.1-->2q37.3 deletion.","volume":"100","author":"Lehman","year":"2001","journal-title":"Am J Med Genet"},{"key":"R67-20261024","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000048775","article-title":"Molecular genetic delineation of 2q37.3 deletion in autism and osteodystrophy: report of a case and of new markers for deletion screening by PCR.","volume":"94","author":"Smith","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"R68-20261024","doi-asserted-by":"crossref","first-page":"156729","DOI":"10.1016\/j.cyto.2024.156729","article-title":"Causal relationship between circulating levels of cytokines and bone mineral density: a Mendelian randomization study.","volume":"182","author":"Xu","year":"2024","journal-title":"Cytokine"},{"key":"R69-20261024","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3389\/fimmu.2017.01227","article-title":"IFN\u03b3 enhances CD64-potentiated phagocytosis of treponema pallidum opsonized with human syphilitic serum by human macrophages.","volume":"8","author":"Hawley","year":"2017","journal-title":"Front Immunol"},{"key":"R70-20261024","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/eurheartj\/ehaf1066","article-title":"GLP-1R agonists and heart failure: novel beneficial effects suggested by Mendelian randomization.","volume":"47","author":"Hu","year":"2026","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:00:18Z","timestamp":1792832418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050444"}},"subtitle":["A Mendelian randomization study"],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":70,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050444","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2025-02-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}